Determinants of Compliance With Glaucoma Therapy

Completed

• Conditions: Open Angle Glaucoma

• Registration Number: NCT01484392
• Lead Sponsor: Legacy Health System

Brief Summary

The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-08
• Study First Submitted: 2011-11-30
• Study First Submitted QC: 2011-12-01
• Study First Posted: 2011-12-02
• Primary Completion: 2013-12
• Study Completion: 2013-12
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-07
• Last Update Posted: 2016-03-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• open angle glaucoma
• be well controlled on current medical therapy
• be using a prostaglandin analogue

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compliance with glaucoma medication at 1 month	1 month after enrollment	Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.
Compliance with glaucoma medication at 3 months	3 months after enrollment	Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

Trial Locations

Locations (1)

Devers Eye Institute; 🇺🇸 Portland, Oregon, United States